|
 |
losartan potassium hydrochlorothiazideThis page contains recent news articles, when available, and an overview of losartan potassium hydrochlorothiazide but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Merck & Co., Inc. today announced that the US Food and Drug Administration (FDA) has approved another new indication for HYZAAR(R), Merck's fixed-dose ... RedOrbit For Patients with Hypertension and Left Ventricular Hypertrophy, FDA ... - Apr 18, 2005 Merck & Co, Inc announced that the US Food and Drug Administration (FDA) has approved another new indication for HYZAAR(reg), Merck's fixed-dose combination ... Medical News Today - Medical News Today (press release) FDA Approves HYZAAR(R) as First/Only Fixed-Dose Combination … - May 16, 2005 Merck & Co, Inc announced that the US Food and Drug Administration (FDA) has approved another new indication for HYZAAR(R), Merck's fixed-dose combination ... Medical News Today - Medical News Today (press release) HYZAAR(R) 100-12.5 mg Offers A New Convenient Dosing Option Within … - Oct 21, 2005 WHITEHOUSE STATION, NJ -- Merck & Co., Inc., today announced the availability of HYZAAR(R) 100-12.5 mg (losartan potassium/hydrochlorothiazide tablets), ... $4.95 - Business Wire - ECNext Company Profile Report - Apr 5, 2008 Consumer. Consumer Products and Services. Food, Beverage and Agriculture. Agriculture. Animal Production. Support Activities for Animal Production ... $50.00 - Revere Reports - Revere FDA Approves HYZAAR as the First and Only Fixed-Dose Combination … - Apr 14, 2005 WHITEHOUSE STATION, NJ -- Merck & Co., Inc. today announced that the US Food and Drug Administration (FDA) has approved another new indication for HYZAAR(R) ... $4.95 - Business Wire - ECNext Titration-Extension Study Shows Losartan-Based Treatment Significantly... - Oct 24, 2005 MONTREAL, CANADA -- October 24, 2005 -- In a population of patients seen in family physician settings, the TITRATION-EXTENSION study demonstrated that the ... DG News Federal Register 2007 - 72 FR 30386 Draft Guidances for Industry … - May 31, 2007 Lisinopril Hydrochlorothiazide; Losartan Potassium Hydrochlorothiazide; Moexipril HCl Hydrochlorothiazide; Olmesartan Medoxomil Hydrochlorothiazide; ... Pay-Per-View - Federal Register 2007 - Loislaw Chuikyo adds 17 new drugs to Japan's NHI list, including seven NCEs.(... - Dec 4, 2006 Japan's Chuikyo (the Central Social Insurance Medical Council) has approved the addition of 12 new active ingredients/17 products (seven New Chemical ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Article: New dosing.(RXs)(Brief article) - Chain Drug Review |... - Apr 23, 2007 New dosing.(RXs)(Brief article) ... find Chain Drug Review articles. The FDA has approved an accelerated dosing schedule for GlaxoSmithKline PLC's Twinrix. Pay-Per-View - Chain Drug Review - HighBeam Research Article: Merck's Hyzaar receives clearance for new indication.(RX/ … - May 2, 2005 Merck's Hyzaar receives clearance for new indication.(RX/BRANDED DRUGS) ... find Chain Drug Review articles. WHITEHOUSE STATION, NJ -- The Food and Drug ... Pay-Per-View - Chain Drug Review - HighBeam Research Banyu Begins Detailing Preminent, a Combination Drug for Hypertension - Dec 11, 2006 Banyu Pharmaceutical has initiated detailing activities for the hypertension treatment Preminent (losartan potassium + hydrochlorothiazide). ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones בורסה: ת"×? 100 עלה ב-1.2%; הדולר: 4.4600 ש' - Jun 15, 2006 ...×ž× ×™×™×ª טבע × ×¡×—×¨×” על רקע קבלת ×?ישור ×˜× ×˜×˜×™×‘×™ ×”-FDA לשיווק טבליות Losartan Potassium Hydrochlorothiazide ... ynet ידיעות ×?×—×¨×•× ×•×ª - ynet ידיעות ×?×—×¨×•× ×•×ª Lipitor receives clearance in Canada.(Brief article) | Article from... - Mar 27, 2006 Lipitor receives clearance in Canada.(Brief article) ... find Chain Drug Review articles. Canadian regulators have approved Pfizer Inc.'s Lipitor for use in ... Pay-Per-View - Chain Drug Review - HighBeam Research 24 New Drugs Approved - Nov 6, 2006 ...six years), Shionogi's OXINORM powder 0.5% (oxycodone HCl hydrate; four years), Genzyme Japan's Aldurazyme 2.9 mg (laronidase; 10 years), Kaketsuken's Anact ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones New indications.(Rx)(restless legs syndrome can be cured by … - Jun 6, 2005 Requip (ropinirole HCl) Tablets, from GlaxoSmithKline, Research Triangle Park, NC, (919) 483-2100, is a new treatment for moderate to severe primary ... Free with registration - Drug Topics - AccessMyLibrary.com New indications. - May 2, 2005 New indications. Zofran (ondansetron hydrochloride) Injection, an antiemetic approved earlier for preventing postoperative nausea and vomiting (PONV) and ... $9.94 - Drug Topics - Alacra Store |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |